(Q41000380)

25 September 2017

Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53. (English)

1 reference

25 September 2017

Tang HY

1

1 reference

25 September 2017

Zhao K

2

1 reference

25 September 2017

Pizzolato JF

3

1 reference

25 September 2017

Fonarev M

4

1 reference

25 September 2017

Langer JC

5

1 reference

25 September 2017

Manfredi JJ

6

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Journal of Biological Chemistry

25 September 2017

1 reference

25 September 2017

273

1 reference

25 September 2017

29156-29163

1 reference

25 September 2017

44

1 reference

25 September 2017

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Radiation-induced cell cycle arrest compromised by p21 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

A transcriptionally active DNA-binding site for human p53 protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Regulation of the specific DNA binding function of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Small peptides activate the latent sequence-specific DNA binding function of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

DNA damage induces phosphorylation of the amino terminus of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Genetic mechanisms of tumor suppression by the human p53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Distribution of LH-RH in subcellular fractions of the basomedial hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

p53 functions as a cell cycle control protein in osteosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Suppression of human colorectal carcinoma cell growth by wild-type p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Wild-type p53 can inhibit oncogene-mediated focus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Activation of the cryptic DNA binding function of mutant forms of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Regulation of mutant p53 temperature-sensitive DNA binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

The blockade of preadipocyte differentiation by protein-tyrosine phosphatase HA2 is reversed by vanadate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.44.29156

21 January 2018

Identifiers

DOI

10.1074/JBC.273.44.29156

1 reference

release_nhbjcdgivfdjhlzycvm4rk7zgm

25 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nhbjcdgivfdjhlzycvm4rk7zgm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference